Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENLIUS

32.000
+0.1500.47%
Volume:4.17M
Turnover:135.68M
Market Cap:17.39B
PE:19.97
High:34.050
Open:31.850
Low:30.750
Close:31.850
Loading ...

FDA Approves Shanghai Henlius Biotech's Investigational New Drug Application for Anti-Neurodegenerative Disease Drug

MT Newswires Live
·
10 Feb

Henlius Doses First Patient in Esophagus Cancer Drug Phase 2 Trial in China

MT Newswires Live
·
10 Feb

BRIEF-Shanghai Henlius Biotech's New Drug Application Of Innovative Small Molecular Hlx99 Approved By U.S. FDA

Reuters
·
10 Feb

Shanghai Henlius Biotech Inc - Co's New Drug Application of Innovative Small Molecular Hlx99 ("Hlx99") Was Approved by U.S. FDA

THOMSON REUTERS
·
10 Feb

Henlius Biotech Strikes Licensing Deal with Dr. Reddy's for Myeloma Drug

MT Newswires Live
·
07 Feb

Stock Track | HENLIUS Soars 10.81% on Deal with Dr. Reddy's Labs for Myeloma Drug

Stock Track
·
07 Feb

BUZZ-Henlius soars on deal with India's Dr. Reddy's Labs for myeloma drug

Reuters
·
07 Feb

Henlius: Co and DR. Reddy's Ink Licensing Deal for Hlx15 Expansion in Europe and U.S.

THOMSON REUTERS
·
06 Feb

BRIEF-Shanghai Henlius Biotech Says License Agreement With Dr. Reddy's For HLX15

Reuters
·
06 Feb

Shanghai Henlius Biotech Inc - DR. Reddy's Shall Pay Company US$33 Mln

THOMSON REUTERS
·
06 Feb

Shanghai Henlius Biotech's Anti-Lung Cancer Injection Gets European Commission's Approval

MT Newswires Live
·
06 Feb

BRIEF-Shanghai Henlius Biotech Says European Commission Approved Serplulimab Injection

Reuters
·
06 Feb

BRIEF-Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Reuters
·
05 Feb

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (Es-Sclc)

THOMSON REUTERS
·
05 Feb

Shanghai Henlius Biotech Inc - European Commission Approved Serplulimab Injection in Combination With Chemotherapy

THOMSON REUTERS
·
05 Feb

Shanghai Henlius Biotech's License Application for Breast Cancer Drug Gets FDA Nod

MT Newswires Live
·
03 Feb

Henlius Biotech's Merger Contract with Fosun Pharma Falls Through; Shares Fall 4%

MT Newswires Live
·
23 Jan

Stock Track | HENLIUS Plummets 10.53% as Shareholders Reject Fosun's Buyout Offer

Stock Track
·
23 Jan

BUZZ-Shanghai Henlius Biotech at 9-month low as shareholders reject buyout offer

Reuters
·
23 Jan

Henlius Biotech shareholders reject take-private offer from China's Fosun

Reuters
·
22 Jan